Point72 Asset Management, L.P. Shows New 6.6% Stake in Summit Therapeutics (SMMT)
Tweet Send to a Friend
In a 13G filing on Summit Therapeutics (NASDAQ: SMMT), Steven Cohen's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
